Press Ganey Announces Plans to Acquire Forsta -- a Leader in the 2021 Gartner® Magic Quadrant™ for Voice of the Customer -- to Accelerate Innovation in the Global Healthcare Experience Industry
Press Ganey, a renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, today announced its plans to acquire Forsta, an industry-leading global provider of customer experience and market research technology. Forsta is named a Leader in the 2021 Gartner® Magic Quadrant™ for Voice of the Customer. The transaction is expected to close in the first or second calendar quarter of 2022, and is subject to regulatory approvals and other customary closing conditions.
“This alliance propels Press Ganey into a new future. Our unparalleled excellence in healthcare consulting, and proprietary data and analytics, will soon be infused with even more innovation and speed by Forsta’s world-class experience and research technology platform,” said Patrick T. Ryan, Chairman and CEO, Press Ganey. “I’m beyond thrilled to welcome Forsta to the Press Ganey family. This is a huge leap forward in helping our customers to do their jobs better every day.”
This pairing drives Press Ganey forward on its path to integrating human-centric, cutting-edge technology into its renowned thought leadership and management expertise in healthcare. Press Ganey’s clients will have access to an even more powerful suite of customer experience (CX), employee experience (EX), and Market Research (MR) technology options on Forsta’s comprehensive platform. Forsta also brings extensive knowledge across a number of industry verticals, such as retail, financial services, travel and hospitality, technology, entertainment and consumer goods. The company works with world-leading brands, including Avon, Best Buy, Canon, eBay, Heathrow Airport and Mars, Inc.
For Forsta, teaming up with healthcare performance advancement pioneer Press Ganey brings new access to investment, growth opportunities and deep consulting and change management experience across the complex healthcare ecosystem. Press Ganey gives Forsta the resources to continue to innovate, at an accelerated pace. And Press Ganey’s gold standard CX and EX capabilities in healthcare will equip Forsta with decades of expertise in this vertical.
“Press Ganey was the first company to truly recognize and respond to the importance of Patient Experience, and the company continues to lead innovation in the field. I’m excited to join forces with such a forward-thinking, highly respected company, and eager for the benefits this investment will bring to our customers,” said Kyle Ferguson, CEO, Forsta.
Combined, Press Ganey and Forsta serve the experience and insights needs of millions of organizations:
- 100% of U.S. News & World Report Best Hospital and Best Children’s Hospital Honor Roll recipients use Press Ganey.
- Press Ganey manages approximately 476 million patient engagements every year.
- Forsta’s HX (Human Experience) platform serves over 5,000 customers in more than 100 countries around the world.
- Forsta supports 9 of the top 10 Market Research Agencies globally.
“This move is the culmination of Press Ganey’s investments to not just be leaders in the healthcare industry, but to lead in experience technology, too. Forsta’s HX platform will allow Press Ganey to make a quantum leap in our technology solutions for our clients,” said Darren Dworkin, Chief Strategy Officer, Press Ganey. “Together, the next generation of patient and customer experience will be better, deeper and truly human-centric.”
About Press Ganey
Press Ganey invented the healthcare performance improvement movement over 35 years ago. Today it offers an integrated suite of solutions that address safety, clinical excellence, patient experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality and experience of care.
About Forsta
Forsta is an Experience and Research Technology Platform that gathers and analyzes data, and translates the findings into shareable actions to inform decision-making and drive growth. Forsta’s technology is designed to discover, analyze and share smart insights packed with real action potential, and help organizations better understand the full Human Experiences of their audiences.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005510/en/
Contact information
Media:
Press Ganey
Ty Fiesel (MP&F)
tfiesel@mpf.com
+1 615 259 4000
Forsta – US
Theresa Tepper
Global Director of Communications
theresa.tepper@forsta.com
Forsta – EU & UK
Sallyanne Heywood
sallyanne@harveyheywood.com
+44 7884 187 074
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom